У нас вы можете посмотреть бесплатно Navigating AFib: Understanding Risk, Treatment Choices, and Shared Decision-Making или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.” Welcome back to Cardiovascular Therapeutics Unplugged, the show where we cut through the noise to bring you real conversations about heart treatments that change lives. In this episode, Dr. Mehra, a board-certified interventional cardiologist, unpacks one of the most common and confusing heart rhythm conditions: atrial fibrillation, or AFib. Millions are diagnosed with AFib each year and are immediately faced with a whirlwind of decisions medications, invasive procedures like ablation, devices such as the Watchman, or sometimes, surprisingly, the advice to do less. But what do these choices actually mean? Why do recommendations vary so much between patients or even from one doctor visit to the next? And how do you cut through the mixed messages to find the right path for you? In this conversation, Dr. Mehra breaks down the basics of AFib: what it is, why it matters, the stages of the condition, and the three pillars of treatment stroke prevention, rhythm control, and rate control. He walks us through new treatment guidelines, the role of medications and blood thinners, the evolving evidence behind procedures like catheter ablation, and when devices might make sense. Most importantly, he emphasizes the importance of individualized care, lifestyle changes, and a shared decision-making process. Whether you’re a recent AFib patient, a family member, or just someone curious about where cardiology is heading, this episode is packed with practical insights designed to empower you and bring clarity to a condition that too often feels overwhelming. Let’s get started. Timestamps 00:00 AFib Diagnosis: Patient Concerns 04:48 AFib: Basics and Evolving Insights 09:03 2023 Atrial Fibrillation Stages 13:31 Stroke Risk Reduction Strategy 16:46 AFib Management: Lifestyle and Medications 19:24 Atrial Fibrillation: Ablation Advancements 22:03 "Stroke Risk Reduction Innovations" 26:44 "Educated Decisions in AFib Care" Quotes, Hooks, and Timestamps "Before you start treating this patient, you gotta make sure that you alleviate their fears and you educate them again, you know, like I said, on the specific disease process." — Dr. Mehra [00:03:45 → 00:03:57] The Ever-Changing Landscape of AFib Treatment: "AFib in particular is confusing. It's not just confusing to the patients, it's confusing to the physicians to manage because again, there's a constant evolution that takes place in the field of cardiology." — Dr. Mehra [00:04:57 → 00:05:12] "Anticoagulation should essentially be continued indefinitely once you have risk stratified the patient based on most commonly what's called a CHADS2-VASC risk score." — Dr. Mehra [00:14:00 → 00:14:13] "more and more emphasis is placed on rhythm control as, um, and early on rhythm control strategy has shown benefit." — Dr. Mehra [00:17:48 → 00:17:58] "Catheter ablation is recommended as a first-line therapy for patients who have symptomatic paroxysmal atrial fibrillation in general to improve their symptoms or to slow progression to a persistent/permanent atrial fibrillation." — Dr. Mehra [00:19:50 → 00:20:10] "The CHADS2-VASc scores essentially risk stratify these patients for us. Now, in patients who have a low CHADS2-VASc score such as 0 or 1, anticoagulation may not be required. In intermediate risk patients who have a score of 2 or above, or higher risk patients who have a you know, higher score, anticoagulation should be considered. And again, a very important shared decision-making process has to be a part of the conversation." — Dr. Mehra [00:21:22 → 00:21:54] "So this device was evaluated in multiple clinical trials, and essentially the original Watchman device demonstrated non-inferiority compared to warfarin for stroke prevention in the PROTECT-AF trial." — Dr. Mehra [00:23:09 → 00:23:27] "I want the patients to be educated. I want them to know about the latest innovations that are out there so that they can, they're not just, you know, walking in with all kinds of confusing information for off the internet and talking to their physician. They, they need to be educated, they need to have knowledge of the latest innovations, and they need to be motivated to take part in their own care." — Dr. Mehra [00:28:37 → 00:28:37] "Understanding that eating right, controlling your blood pressure, controlling your cholesterol, not drinking heavily, not smoking, all those things, as well as treating things like sleep apnea, are very, very important to managing atrial fibrillation." — Dr. Mehra [00:29:11 → 00:29:29] 29:47 AFib: Understanding Choices Clearly